Dr. Al-Ghazali indicated that the recent studies that were discussed during the conference showed that immunotherapy can be used before surgery, which is new in surgeries related to tumors in general and lung tumors in particular, as the cure rate increases by 34%, and that the conference recommended the use of this in all specialties. In all university hospitals and hospitals of the Ministry of Health, which contributes to the treatment of patients well using immunotherapies, with the necessity of conducting early detection and conducting an extensive medical survey through the National Health Initiative similar to the 100 Million Health Initiative.
